Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological treatment of chronic heart failure.

Literature DB >> 16937030

Pharmacological treatment of chronic heart failure.

Rachele Adorisio¹, Leonardo De Luca, Joseph Rossi, Mihai Gheorghiade.

Abstract

Heart failure (HF) is associated with a high morbidity and mortality in the Western World. Our knowledge of the epidemiology, pathophysiology, and therapy has improved dramatically during the last 20 years. Pharmacological treatment, as it stands today, is a combination of preventive and symptomatic strategies. The mainstay life-saving drugs are angiotensin-converting enzyme inhibitors and beta-blockers. Additional benefits are obtained when angiotensin-receptor blockers or aldosterone antagonists are added. Digitalis and/or diuretics are useful for symptom reduction. In addition, combination therapy with hydralazine and isosorbide dinitrate is recommended in African Americans.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2006 PMID： 16937030 DOI： 10.1007/s10741-006-9482-z

Source DB: PubMed Journal: Heart Fail Rev ISSN： 1382-4147 Impact factor: 4.214

110 in total

1. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.

Authors: F Zannad; F Alla; B Dousset; A Perez; B Pitt
Journal: Circulation Date: 2000-11-28 Impact factor: 29.690

Review 2. Clinical practice. Diastolic heart failure.

Authors: Gerard P Aurigemma; William H Gaasch
Journal: N Engl J Med Date: 2004-09-09 Impact factor: 91.245

3. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.

Authors: N J Brown; D Ryder; J V Gainer; J D Morrow; J Nadeau
Journal: J Pharmacol Exp Ther Date: 1996-11 Impact factor: 4.030

Review 4. Digoxin. A neurohormonal modulator in heart failure?

Authors: M Gheorghiade; D Ferguson
Journal: Circulation Date: 1991-11 Impact factor: 29.690

5. Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease.

Authors: G Ambrosio; S Betocchi; L Pace; M A Losi; P Perrone-Filardi; A Soricelli; F Piscione; J Taube; F Squame; M Salvatore; J L Weiss; M Chiariello
Journal: Circulation Date: 1996-11-15 Impact factor: 29.690

6. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

Authors: F Waagstein; K Caidahl; I Wallentin; C H Bergh; A Hjalmarson
Journal: Circulation Date: 1989-09 Impact factor: 29.690

7. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors: M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal: N Engl J Med Date: 1996-10-10 Impact factor: 91.245

8. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.

Authors: J Hensen; W T Abraham; J A Dürr; R W Schrier
Journal: Am J Nephrol Date: 1991 Impact factor: 3.754

9. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Authors: Wendy A Gattis; Christopher M O'Connor; Dianne S Gallup; Vic Hasselblad; Mihai Gheorghiade
Journal: J Am Coll Cardiol Date: 2004-05-05 Impact factor: 24.094

Review 10. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.

Authors: A D Struthers
Journal: J Card Fail Date: 1996-03 Impact factor: 5.712

9 in total

Review 1. Mesenchymal stem cells for the treatment of heart failure.

Authors: Shunsuke Ohnishi; Hajime Ohgushi; Soichiro Kitamura; Noritoshi Nagaya
Journal: Int J Hematol Date: 2007-07 Impact factor: 2.490

2. Future g protein-coupled receptor targets for treatment of heart failure.

Authors: Giuseppe Rengo; Anastasios Lymperopoulos; Walter J Koch
Journal: Curr Treat Options Cardiovasc Med Date: 2009-08

Review 3. Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence.

Authors: Cara Tannenbaum; Kristina Johnell
Journal: Drugs Aging Date: 2014-02 Impact factor: 3.923

4. The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells.

Authors: Francesca Felicia Caputi; Elio Acquas; Sanjay Kasture; Stefania Ruiu; Sanzio Candeletti; Patrizia Romualdi
Journal: BMC Complement Altern Med Date: 2018-01-10 Impact factor: 3.659

5. Adverse drug events and the associated factors in patients with chronic Chagas disease.

Authors: Luiza Braz da Cunha Lopes; Raquel Rodrigues Pereira; Patricia Mello Andrade; Fernanda Martins Carneiro; Mauro Felippe Felix Mediano; Sophia Isabel Linnemann Kilgore; Alejandro Marcel Hasslocher-Moreno; Andréa Silvestre de Sousa; Manoel Marques Evangelista Oliveira; Roberto Magalhães Saraiva; Marcelo Teixeira de Holanda; Gilberto Marcelo Sperandio da Silva
Journal: Rev Soc Bras Med Trop Date: 2020-04-22 Impact factor: 1.581

9. Clinical efficacy and safety of Danhong injection for the treatment of chronic heart failure: A protocol for systematic review.

Authors: Lihua Han; Chuan Wang; Dongfeng Yao; Bin Wang; Zhen Zhang; Jiping Liu
Journal: Medicine (Baltimore) Date: 2020-04 Impact factor: 1.817